Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials

Ductal Carcinoma In Situ (DCIS) can progress to invasive breast cancer, but most DCIS lesions never will. Therefore, four clinical trials (COMET, LORIS, LORETTA, AND LORD) test whether active surveillance for ...

Source: Cancer Imaging - April 5, 2024 Category: Radiology Authors: Sena Alaeikhanehshir, Madelon M. Voets, Frederieke H. van Duijnhoven, Esther H. lips, Emma J. Groen, Marja C. J. van Oirsouw, Shelley E. Hwang, Joseph Y. Lo, Jelle Wesseling, Ritse M. Mann and Jonas Teuwen Tags: Research article Source Type: research